Lukasz Kuzma/LinkedIn
Feb 16, 2026, 14:44
Lukasz Kuzma: NOAC Monotherapy vs NOAC Plus Clopidogrel in AF Beyond One Year After DES
Lukasz Kuzma, Research Professor at University of Liverpool, shared a post on X about a recent article he and his colleague co-authored, adding:
“In our NEJM editorial with ESC Stroke Chair, we highlight the first RCT in AF more than 1 year after DES showing that NOAC monotherapy was not noninferior and statistically superior to NOAC plus clopidogrel for net adverse clinical events also with less bleeding.”
Title: Thromboprophylaxis for Atrial Fibrillation in Patients with Drug-Eluting Stents
Authors: Gregory Y.H. Lip and Lukasz Kuzma
Read the Full Article on The New England Journal of Medicine.
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 06:17Neha Rastogi Panda: Precision Diagnosis and Organ Preservation in Splenic Abscess
-
Oct 16, 2026, 05:53Alejandro González Veliz: Looking Beyond Coronary Anatomy to Understand Ischemia
-
Oct 16, 2026, 04:16Asmaa M. Gouda: Advancing Blood Bank Leadership at Alexandria University Hospitals
-
Oct 16, 2026, 03:52Saja Al-Zamili: Minimally Invasive Hematoma Evacuation in Intracerebral Hemorrhage
-
Oct 16, 2026, 03:13Bhumika Satija: Beyond the Diploma A Growing Passion for Blood Banking and Transfusion Medicine
-
Oct 16, 2026, 03:03Jamie Nash: Microfluidics in Transfusion Medicine Advancing Blood Component Quality Assessment
-
Oct 16, 2026, 02:53World Thrombosis Day 2026 Advancing Women’s Health Through Better Thrombosis Research and Care – World Thrombosis Day
-
Oct 16, 2026, 02:42Areej Wasi: Myocardial Infarction in Young Adults Advancing Cardiology Education and Medical Leadership
-
Oct 16, 2026, 02:33Mehak Trehan: ASH 2026 Myelofibrosis Guidelines 10 Practical Takeaways for Clinical Practice